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Here we undertook to identify colonization and gastric disease-promoting factors of the human gastric
pathogen Helicobacter pylori as genes that were induced in response to the stomach environment. Using
recombination-based in vivo expression technology (RIVET), we identified six promoters induced in the host
compared to laboratory conditions. Three of these promoters, designated Pivi10, Pivi66, and Pivi77, regulate
genes that H. pylori may use to interact with other microbes or the host. Pivi10 likely regulates the mobA, mobB,
and mobD genes, which have potential roles in horizontal gene transfer through plasmid mobilization. Pivi66
occurs in the cytotoxin-associated gene pathogenicity island, a genomic region known to be associated with
more severe disease outcomes, and likely regulates cagZ, virB11, and virD4. Pivi77 likely regulates HP0289, an
uncharacterized paralogue of the vacA cytotoxin gene. We assessed the roles of a subset of these genes in
colonization by creating deletion mutants and analyzing them in single-strain and coinfection experiments. We
found that a mobABD mutant was defective for murine host colonization and that a cagZ mutant outcompeted
the wild-type strain in a coinfection analysis. Our work supports the conclusion that RIVET is a valuable tool
for identifying H. pylori factors with roles in host colonization.
Helicobacter pylori is a gram-negative bacterium that colo-
nizes the stomachs of 50% of the world’s population (66).
About 10% of H. pylori infections result in severe gastritis,
gastric ulcers, gastric cancer, and mucosa-associated lymphoid
tissue lymphoma (67, 86). Variability in the genetics of both
the infecting H. pylori strains and the infected hosts likely
contributes to the wide range of disease outcomes (8). The
goals of this work were to identify additional H. pylori virulence
factors that contribute to host colonization and/or to disease
development and to characterize their roles in virulence.
Several virulence factors that aid H. pylori in colonization of
the host and contribute to disease development have been
identified by a variety of methods. One of these factors is the
urease enzyme that H. pylori needs to survive in the low-pH
gastric lumen as it makes its way to the gastric mucosa, which
has a more neutral pH (58). The urease enzyme buffers the
bacterium by converting host-produced urea into NH3 and
CO2. H. pylori also requires several motility and chemotaxis
genes for colonization, presumably so that it can locate and
move to its preferred site of infection and remain there (27, 28,
31, 64). Autotransporters, including the VacA protein, contrib-
ute to host colonization in several ways, possibly by damaging
epithelial cells and by interfering with antigen presentation
(25, 57, 68, 71, 83). Other putative autotransporters encoded
by babA and sabA help H. pylori adhere to the gastric epithe-
lium, likely preventing bacterial shedding with epithelial cell
turnover and mucus flow (40, 54). Although not required for
host colonization, the H. pylori virulence factor NapA (neutro-
phil activating protein A) contributes to disease development,
as it promotes inflammation by attracting neutrophils and
monocytes to the site of infection and also stimulates the re-
lease of reactive oxygen species from leukocytes (75). Another
protein found to contribute to inflammation is OipA (outer
inflammatory protein A) (91). Finally, a quite well-known H.
pylori virulence factor is the cytotoxin-associated gene (CAG)
pathogenicity island and the effector CagA. The type IV se-
cretion apparatus encoded by CAG pathogenicity island genes
promotes inflammation and injection of the effectors CagA
and peptidoglycan into the host epithelial cell and provokes
cell dysfunction that can lead to cell transformation (35,
60, 88).
Recently, several semiglobal screens have been used to iden-
tify additional H. pylori genes that are required for host colo-
nization and/or contribute to gastric disease. Two studies used
in vivo screens with libraries of transposon-mutagenized H.
pylori strains to identify genes required for H. pylori host col-
onization (6, 41). In both of these cases, the H. pylori strains
used to infect the host were compared with strains recovered
from the stomach to find genes required for viability in the host
(6, 41). These studies identified some genes that the strains had
in common and some unique genes. Two other studies focused
on H. pylori genes induced in response to the host. Two of the
known H. pylori virulence factors, UreA and NapA, were in-
duced during infection of the host (9), supporting the conclu-
sion that this strategy is a good strategy for identifying other
virulence factors. One study used selective capture of tran-
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scribed sequence analysis to isolate H. pylori transcripts that
were induced in human biopsies and experimentally infected
gerbils and compared their expression under these conditions
with the expression in culture (34). A second study used mi-
croarrays to compare H. pylori in vivo gene expression to ex-
pression under in vitro culture conditions (78). Although these
analyses identified genes induced during host infection, each of
them had its limitations. For example, the transposon mu-
tagenesis screens did not analyze essential genes, and the tran-
script induction screens identified only genes that were in-
duced at the time of RNA isolation. Thus, our goal was to
identify new H. pylori virulence factors that may have been
missed by these analyses.
Here we describe the use of recombination-based in vivo
expression technology (RIVET) to identify H. pylori promoters
induced in response to the murine host. RIVET is a variant of
the original in vivo expression technology (53) in which a
promoter transcriptional event is captured permanently as a
conversion of the infecting strain from antibiotic resistant to
antibiotic sensitive (Fig. 1) (17). The RIVET approach has
been used with Vibrio cholerae, Lactobacillus plantarum, Staph-
ylococcus aureus, Mycobacterium tuberculosis, and Bordetella
pertussis (14, 18, 51, 76, 87). Here we describe how we modified
the RIVET system for use with H. pylori. Using the RIVET
system, we screened a 3,000-member library of potential H.
pylori promoters in mice and found that 6 of them were reliably
host induced. The genes regulated by these promoters include
three genes with potential roles in H. pylori secretion systems;
these genes encode Mob-like proteins potentially required for
bacterial conjugation, the CagZ protein present in the CAG
pathogenicity island, and the VacA paralogue encoded by
HP0289. To determine whether these gene products affected
animal colonization, we constructed and analyzed mobABD
and cagZ gene deletion mutants. We found that the H. pylori
mobABD mutant was defective for host colonization, while
the cagZ mutant actually outcompeted the wild-type parent
strain in competition coinfection analyses. Our work supports
the conclusion that the RIVET system is a valuable tool for
identifying H. pylori genes important for host colonization.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and antibiotics. H. pylori strain mG27 is
a mouse-adapted descendant of clinical isolate G27 (19, 23). mG27 was gener-
ated by serially passaging the G27 H. pylori strain in mice (19). All H. pylori
strains were cultured on Columbia horse blood agar (CHBA) or in brucella broth
supplemented with 10% fetal bovine serum (BB10) and were grown at 37°C
under microaerobic conditions with a gas mixture containing 5 to 10% O2, 10%
CO2, and 80 to 85% N2. Antibiotics selective for H. pylori were added at a
concentration of either 13 g/ml (for chloramphenicol [Cm]) or 15 g/ml (for
kanamycin [Km]). Escherichia coli was cultured on Luria-Bertani (LB) agar
plates or in liquid media containing ampicillin (Amp) at a final concentration of
100 g/ml. E. coli strains were stored at 80°C in 25 to 40% glycerol. H. pylori
strains were stored at 80°C in brain heart infusion media supplemented with
10% fetal bovine serum, 1% (wt/vol) -cyclodextrin, 25% glycerol, and 5%
dimethyl sulfoxide.
Plasmid construction. (i) pcat-T-tnpR. To identify promoters that are induced
during infection of animals, we created plasmid pcat-T-tnpR, which has a pro-
moterless tnpR gene that recombines in the H. pylori chromosome (Fig. 2A). This
plasmid contains the Campylobacter coli gene for Cm resistance (Cmr) (cat), a
strong E. coli transcriptional terminator (rrnBT1T2) (62), and a promoterless
tnpR gene, all of which are flanked by sequences of the H. pylori rdxA gene. cat
is transcribed from its own promoter, and the strong E. coli terminator rrnBT1T2,
prevents read-through transcription into tnpR (19). The pcat-T-tnpR plasmid
directs recombination into the middle of the rdxA locus on the H. pylori chro-
mosome (80). rdxA was used because loss of this gene does not alter in vitro
growth rates or the ability to infect mice (84). Upstream of the tnpR gene there
is a unique BglII site into which the H. pylori genomic library was cloned.
(ii) pAW2rkr2. The res1-Km-res1 cassette was generated by cloning the C. coli
aphA3 gene that confers Kmr (designated Km) between two res1 sequences from
plasmid pSL134 (82). The res1-Km-res1 cassette was subsequently cloned into the
HindIII site of pMW2 (19) in the cloned intergenic region between the conver-
gently expressed H. pylori genes HP0294 and HP0295. The resulting plasmid was
designated pAW2rkr2 (19). Plasmid pAW2rkr2 targets res1-Km-res1 to the
HP0294-HP0295 intergenic locus. Strain mG27 bearing this construct was des-
ignated ACHP17 (Table 1). Studies of H. pylori strains mG27 and SS1 containing
this insertion indicated that the modification had no deleterious effects on either
growth or mouse colonization (data not shown).
Generating a library of potential promoters, pcat-T-lib-tnpR. We generated a
library of potential promoters by ligating partially Sau3A-digested genomic DNA
isolated from H. pylori strain mG27 into the BglII site of the pcat-T-tnpR vector
(Fig. 2A). We selected Sau3A-digested DNA fragments ranging from 1 to 4 kb
long for the library by agarose gel purification. The ligated plasmids were elec-
troporated into E. coli DH10B and plated onto LB medium containing Amp.
Approximately 12,000 individual Ampr colonies were pooled and grown in LB
broth containing Amp, and DNA was isolated using a midiprep kit (Qiagen) to
generate pcat-T-lib-tnpR.
Generating the H. pylori RIVET library. To create the H. pylori RIVET library,
pcat-T-lib-tnpR was used to transform H. pylori strain ACHP17 (mG27
HP0294/HP0295::res1-Km-res1) (Table 1) to Cmr (Fig. 2B). To minimize the
number of in vitro-expressed promoter-containing clones in our H. pylori RIVET
library, we passaged Cmr transformants on CHBA containing Cm twice before
selecting for Kmr. This step allowed in vitro-expressed clones to transcribe tnpR,
resolve res1-Km-res1, and convert to Kms (Fig. 2C). Clones that did not express
tnpR in the lab remained Kmr and were used to generate frozen stocks for our
H. pylori RIVET library. Independent library clones were pooled to obtain
batches containing 10 clones and stored at 80°C. The H. pylori RIVET library
consisted of 3,000 clones.
FIG. 1. RIVET for use with H. pylori. (A) An H. pylori RIVET
strain contains two RIVET components located in the chromosome, a
promoterless tnpR gene that encodes the site-specific recombinase
integrated at the H. pylori rdxA locus (diagram 1) and a cassette in
which the aphA3 gene (also designated Km) that confers Kmr is cloned
between res1 sequences (res1-Km-res1) integrated at the HP0294-
HP0295 intergenic locus (diagram 2). In the absence of an upstream
promoter, tnpR is not expressed and the H. pylori strain remains Kmr.
(B) In the presence of an upstream promoter (P), tnpR is expressed
(diagram 1), and the TnpR recombinase binds the res1 sequences to
catalyze removal of the Km gene cloned between these sequences
(diagram 2), converting the H. pylori strain to Kms (diagram 3).
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Analysis of pcat-T-lib-tnpR and the H. pylori RIVET library. Both pcat-T-lib-
tnpR and the H. pylori RIVET library were analyzed to determine the diversity
and the level of H. pylori genome coverage. We analyzed 30 clones obtained from
the pcat-T-lib-tnpR library and 30 clones from the H. pylori RIVET library by
isolating plasmid DNA and genomic DNA, respectively. The cloned H. pylori
DNA was amplified from the templates by PCR using oligonucleotide rrnB1 or
catseqst and oligonucleotide tnpRbk75 (Table 2). The presence and approximate
sizes of the cloned H. pylori DNA fragments were determined by agarose gel
electrophoresis. Cloned fragments that were similar sizes were sequenced to
determine their uniqueness (Berkeley DNA Sequencing Facility, Berkeley CA).
The levels of H. pylori genome coverage for the pcat-T-lib-tnpR and H. pylori
RIVET libraries were determined using the following formula: N  ln
(1  P)/ln(1  I/G), where P is the probability of obtaining all clones (we used
99%), I is the insert size (we used the calculated average insert sizes, 1.0 kb for
the pcat-T-lib-tnpR library and 0.65 kb for the H. pylori RIVET library), and G
is the genome size (1.8  103 kb) (2a). Based on our calculations, the pcat-T-
lib-tnpR library covered the H. pylori genome 4.7 times and the H. pylori
RIVET library covered 84% of the H. pylori genome.
Screening the H. pylori RIVET library for in vivo-induced promoters. All
animal protocols were approved by the Institutional Animal Use and Care
Committee. Fifty H. pylori RIVET strains were screened simultaneously for
promoter induction in each of two FVB/N mice (Charles River) (Fig. 2D). Five
groups of 10 H. pylori RIVET strains were grown on CHBA containing Km to
maintain Kmr. Immediately prior to infection of mice, the 50 strains were resus-
pended in BB10. The bacterial concentration was determined by determining the
optical density at 600 nm (OD600), and the culture volume was adjusted with
BB10 to obtain a bacterial concentration of 5  107 cells/ml. Approximately 1
ml of the RIVET strain mixture was used to infect each of two FVB/N mice that
were 4 to 6 weeks old by oral gavage by using a 20-gauge, 38-mm-long needle
(Popper). Infections were allowed to persist for 2 weeks, after which we har-
vested and processed the mouse stomachs as described by Ottemann and Lo-
wenthal (64). In brief, the stomachs were homogenized in 500 l BB10 using a
sterile pestle, and dilutions were plated on CHBA plates. The plates were
incubated for 4 days at 37°C under microaerobic conditions. H. pylori colonies
from these plates were then replica plated on both plates containing CHBA and
plates containing CHBA supplemented with Km to identify Kms H. pylori
RIVET strains that induced expression of tnpR in vivo. Kms RIVET strains were
isolated from the corresponding CHBA plates for further analysis (Fig. 2D).
These strains were designated using ivi (for in vivo-induced RIVET strain) plus
a number (e.g., ivi2), and the H. pylori DNA cloned upstream of tnpR in these
strains were designated using Pivi (for in vivo-induced promoter) plus a number
(e.g., Pivi2).
Identifying in vivo-induced promoters. To obtain the sequence representing
each Pivi clone, we isolated genomic DNA from the Kms H. pylori RIVET strains
isolated from mice by using a Wizard genomic DNA purification kit (Promega).
We then amplified the cloned Pivi region using oligonucleotides that annealed to
the cat gene upstream of the cloned region (oligonucleotide catseqst) and the
tnpR gene downstream of the cloned region (oligonucleotide tnpRbk75) (Table
2) by PCR. The sizes of the cloned fragments were estimated by agarose gel
electrophoresis and were determined exactly by sequencing. The Pivi clones were
sequenced using the catseqst and tnpRbk75 oligonucleotides (University of Cal-
ifornia Berkeley DNA sequencing facility). The genomic and endogenous plas-
mid locations of the Pivi clones were determined by comparing the sequences of
the clones to the unpublished sequence of the H. pylori G27 strain genome (see
Table S1 in the supplemental material). An operon analysis was done using the
website http://www.microbesonline.org/.
Reconstruction of in vivo-induced strains. Since the H. pylori RIVET strains
that were induced in the host removed the res1-Km-res1 cassette (and were
therefore Kms), we reintroduced the res1-Km-res1 cassette into the original locus
of each of these strains before we performed our secondary analysis. One Kms
mouse output strain for each of the 13 unique Kms ivi strains was naturally
transformed with pAW2rkr2. Transformants were selected based on Kmr, and
proper integration was verified by PCR using oligonucleotides that flanked the
site of integration, oligonucleotides HP0294end and HP0295end (Table 2).
Testing promoter induction in vitro and in vivo. Each of the 13 reconstructed
ivi strains (strains whose designations end with R in Table 1) was analyzed to
determine promoter induction conferred by the Pivi clones in the lab and in
FVB/N mice. The reconstructed ivi strains were grown on CHBA containing Km
prior to these analyses to maintain Kmr. In vitro promoter induction was carried
out by passaging each reconstructed ivi strain on CHBA without Km for 2 weeks
(five passages on fresh CHBA). Cells of the H. pylori reconstructed ivi strains
were then resuspended in BB10 and plated on CHBA to obtain single colonies
(200 colonies/plate). After the plates were incubated for 4 days at 37°C under
microaerobic conditions, the H. pylori colonies were replica plated on both plates
containing CHBA and plates containing CHBA supplemented with Km. The
level of promoter induction (expressed as a percentage) was calculated by divid-
ing the number of Kms colonies by the total number of colonies and multiplying
the result by 100. To determine the in vivo induction conferred by the Pivi
regions, each reconstructed ivi strain was used independently to infect a group of
FVB/N mice. After 2 weeks of infection, the mouse stomachs were harvested and
plated on CHBA to isolate H. pylori. The plates were incubated for 4 days at 37°C
under microaerobic conditions, and then colonies were replica plated on both
plates containing CHBA and plates containing CHBA supplemented with Km to
determine the number of H. pylori cells that had converted to Kms while the
strains were in mice. The level of promoter induction in vivo (expressed as a
percentage) was calculated by dividing the number of Kms colonies by the total
number of colonies analyzed and multiplying the result by 100. The statistical
significance of differences between promoter induction in vivo and promoter
induction in vitro was calculated using the two-tailed Student t test.
Construction of H. pylori gene deletion mutants. We generated deletions of
genes regulated by our in vivo-induced promoters by replacing a gene of interest
with a nonpolar allele of the C. coli cat gene (84) that confers Cmr. Each gene
replacement cassette was generated using a PCR sewing strategy (22). In brief,
chromosomal regions upstream and downstream of the gene of interest were
amplified using in each case (i) one oligonucleotide that annealed to the chro-
mosome and (ii) another oligonucleotide that annealed to the chromosome and
FIG. 2. Construction and screening of the pcat-T-lib-tnpR and H.
pylori RIVET libraries. (A) The H. pylori RIVET library in E. coli
(pcat-T-lib-tnpR) was generated by cloning Sau3A-digested H. pylori
genomic DNA into the BglII site upstream of tnpR in plasmid pcat-T-
tnpR. Approximately 12,000 independent clones were propagated in E.
coli, and the average insert size was 1.0 kb. (B) The H. pylori RIVET
library (pcat-T-lib-tnpR) was integrated into the H. pylori rdxA chro-
mosomal locus of H. pylori strain ACHP17, which contained the res1-
Km-res1 cassette at an unlinked chromosomal locus. RIVET library
transformants were selected on Cm-containing media. (C) In vitro
expression clones were removed from the H. pylori RIVET library as
transformants that converted to Kms in the lab. A total of 3,340 Cmr
Kmr transformants were in our H. pylori RIVET library. (D) Fifty
independent H. pylori RIVET library clones were simultaneously
screened in each of two mice for in vivo induction (conversion to Kms).
After 2-weeks of infection, mouse stomachs were harvested and plated
on CHBA containing Cm to isolate H. pylori. The plates containing
CHBA supplemented with Cm were then replica plated on CHBA
containing Km (Km media) to identify in vivo-induced Kms clones.
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either the start or end of the cat gene. A third PCR product representing the
nonpolar cat allele was generated using oligonucleotides catR2 and catF (Table
2). The PCR products representing the upstream chromosomal region, the
downstream chromosomal region, and the cat gene were generated indepen-
dently, purified using an agarose gel (GFX PCR DNA and gel band purification
kit; GE Healthcare), and then combined. The mixture of PCR products was used
as a template with the oligonucleotides that annealed to the far upstream and
downstream PCR product regions. The large PCR products generated in these
reactions (upstream region-cat-downstream region) were purified using an aga-
rose gel and used to naturally transform H. pylori strains SS1 (47) and mG27 (19)
to Cmr as previously described (72). All mutant strains were found to be wild
type for motility by microscopic inspection and to be wild type for urease activity
using a pH indicator buffer (Difco urea broth; Difco) (data not shown).
Mouse colonization analyses. H. pylori strains used for colonization analyses
were passaged minimally in the lab on CHBA (two or three times) and then
removed either from CHBA after growth for 18 h or from a BB10 culture
grown for 18 h. H. pylori strains grown on CHBA were transferred to BB10
prior to infection and analyzed to determine motility and the bacterial cell
concentration (OD600). H. pylori strains grown in BB10 were analyzed directly to
determine motility and the bacterial cell concentration (OD600). Approximately
1 ml of an H. pylori culture containing 5  107 to 5  108 CFU/ml was used to
inoculate mice by oral gavage. For single-infection studies, either a mutant H.
pylori strain or the appropriate wild-type control strain was used to infect mice.
For the coinfection analysis, the mutant and wild-type strains were grown sepa-
rately and analyzed to determine their motilities and bacterial cell concentrations
(OD600) before the cultures were mixed and used for coinfection. The bacterial
cell concentrations were used to generate a mixed culture containing approxi-
mately equal numbers of cells of the mutant and wild-type strains. The actual
bacterial cell concentration was determined more accurately by culture dilution
and plating. Infections were allowed to persist for 2 weeks, after which the mouse
stomachs were isolated and plated on CHBA as described above. The stomachs
of mice infected with the mutant strains were plated on CHBA containing Cm,
and the stomachs of mice infected with the wild-type strain were plated on
CHBA. The stomachs of mice coinfected with both the mutant and the wild-type
strain were plated on both CHBA containing Cm and CHBA. The competitive
index was calculated as follows: (CFU/g for the mutant strain output/CFU/g for
the wild-type strain output)/(CFU/g for the mutant strain input/CFU/g for the
wild-type strain input).
RESULTS
We adapted the RIVET system used with great success by
Camilli and Mekalanos (18) for use with H. pylori and used it
to identify promoters induced in response to murine stomachs.
Adapting V. cholerae RIVET for use with H. pylori required (i)
creation of an H. pylori antibiotic resistance reporter for tnpR
recombinase expression flanked by res1 sites (we used Kmr
[res1-Km-res1]) and (ii) creation of an H. pylori library of
genomic promoters fused to the tnpR gene (pcat-T-lib-tnpR).
When tnpR expression was directed by the cloned H. pylori
DNA, TnpR bound the res1 sequences and catalyzed the re-
moval of the intervening Kmr cassette (Fig. 1).
We changed the original RIVET system from a V. cholerae-
specific antibiotic resistance (tetracycline) system to a system
TABLE 1. Strains and plasmids used in this study
H. pylori strain or
plasmid Description Reference
H. pylori strains
mG27 Mouse-adapted G27 strain 19
SS1 47
ACHP17 mG27 HP0294/HP0295::res1-aphA3-res1 19
ivi2 rdxA::cat-T-Pivi2-tnpR HP0294/HP0295::res1 This study
ivi7 rdxA::cat-T-Pivi7-tnpR HP0294/HP0295::res1 This study
ivi10 rdxA::cat-T-Pivi10-tnpR HP0294/HP0295::res1 This study
ivi11 rdxA::cat-T-Pivi11-tnpR HP0294/HP0295::res1 This study
ivi23 rdxA::cat-T-Pivi23-tnpR HP0294/HP0295::res1 This study
ivi39 rdxA::cat-T-Pivi39-tnpR HP0294/HP0295::res1 This study
ivi50 rdxA::cat-T-Pivi50-tnpR HP0294/HP0295::res1 This study
ivi51 rdxA::cat-T-Pivi51-tnpR HP0294/HP0295::res1 This study
ivi63 rdxA::cat-T-Pivi63-tnpR HP0294/HP0295::res1 This study
ivi66 rdxA::cat-T-Pivi66-tnpR HP0294/HP0295::res1 This study
ivi67 rdxA::cat-T-Pivi67-tnpR HP0294/HP0295::res1 This study
ivi70 rdxA::cat-T-Pivi70-tnpR HP0294/HP0295::res1 This study
ivi77 rdxA::cat-T-Pivi77-tnpR HP0294/HP0295::res1 This study
ivi2R rdxA::cat-T-Pivi2-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi7R rdxA::cat-T-Pivi7-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi10R rdxA::cat-T-Pivi10-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi11R rdxA::cat-T-Pivi11-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi23R rdxA::cat-T-Pivi23-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi39R rdxA::cat-T-Pivi39-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi50R rdxA::cat-T-Pivi50-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi51R rdxA::cat-T-Pivi51-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi63R rdxA::cat-T-Pivi63-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi66R rdxA::cat-T-Pivi66-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi67R rdxA::cat-T-Pivi67-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi70R rdxA::cat-T-Pivi70-tnpR HP0294/HP0295::res1-aphA3-res1 This study
ivi77R rdxA::cat-T-Pivi77-tnpR HP0294/HP0295::res1-aphA3-res1 This study
mobABD mG27 mobABD::cat This study
cagZ SS1 cagZ::cat This study
Plasmids
pcat-T-tnpR cat gene-E. coli rrnBT1T2-BglII-tnpR 19
pAW2rkr2 res1-aphA3-res1 cassette at HindIII site of pMW2 19
VOL. 76, 2008 RIVET IDENTIFIES H. PYLORI COLONIZATION FACTORS 5635
that works with H. pylori. To do this, we chose a Kmr gene
(aphA3 or Km) that carries its own promoter and flanked it
with recombinase recognition sequences (res1) to create res1-
Km-res1. We used the mutant res sequence res1, which contains
a mutation at the crossover site resulting in decreased recom-
bination efficiency (59). We hypothesized that use of the res1
allele would allow us to identify promoters that were expressed
to some extent in vitro but exhibited elevated expression in the
host. The res1-Km-res1 cassette was cloned into a plasmid that
directed its integration into the chromosomal region between
open reading frames HP0294 and HP0295 (19). We integrated
this construct into the chromosome of H. pylori strain mG27 to
ensure that a single copy was present and to ensure that it was
stably maintained. H. pylori strain mG27 is a mouse-adapted
version of the commonly used H. pylori strain G27 (19, 79).
Integration at the HP0294-HP0295 site occurred by double-
crossover gene replacement and did not affect the growth or
virulence of H. pylori strains mG27 and SS1 (data not shown).
We verified that res1-Km-res1 integrated into the proper chro-
mosomal region by selecting for Kmr transformants and by
performing PCR with oligonucleotide primers that flanked the
insertion site (data not shown). The resulting strain was des-
ignated ACHP17 (Table 1).
Generating the library of potential promoters (pcat-T-lib-
tnpR). To generate pcat-T-lib-tnpR (Table 1), we created a
plasmid with a promoterless tnpR gene and cloned a partially
Sau3A-digested H. pylori genomic library upstream of tnpR
(Fig. 2A). The plasmid contained the cat gene, which conferred
Cmr, followed by a strong E. coli terminator, the site for H.
pylori library insertion, and the promoterless tnpR gene, all
flanked by sequences of the H. pylori gene rdxA. Expression of
the cat gene is directed by its endogenous promoter, and the E.
coli terminator prevents read-through transcription of tnpR
(19). We used the wild-type tnpR allele, which had a wild-type
ribosome binding site, for our work (48). pcat-T-lib-tnpR was a
collection of 12,000 independent colonies. Our analysis of 30
library clones suggested that 70% of them contained inserts
with an average size of 1.0 kb (data not shown). Our analysis
also indicated that the library was diverse and covered the
1.8-Mb H. pylori genome 4.7 times (see Materials and Meth-
ods). The rdxA sequences flanking cat-T-lib-tnpR in pcat-T-lib-
tnpR targeted integration of this plasmid into the H. pylori
chromosomal rdxA locus by double-crossover homologous re-
combination (Fig. 2B). The rdxA locus is commonly used for
integrating exogenous DNA into the H. pylori chromosome
(80).
Creation of the H. pylori RIVET library. To construct the H.
pylori RIVET library strains, pcat-T-lib-tnpR was used to trans-
form H. pylori strain ACHP17 (HP0294/HP0295::res1-Km-res1)
(Table 1) to Cmr (Fig. 2B). Each Cmr transformant was passaged
twice in Cm-containing media before selection on Km-containing
media and subsequent freezing. We initially passaged the Cmr
transformants without Km selection to allow promoters that were
expressed in the lab to convert the strains carrying them to Kms
(Fig. 2C). We were interested in promoters that were not ex-
pressed in the lab or were expressed at very low levels in the lab
and thus in bacteria that retained Kmr (res1-Km-res1). The
genomic DNA of 30 Cmr H. pylori transformants was screened by
PCR using oligonucleotides that annealed upstream and down-
stream of the genomic DNA fragment to assess whether this
subset of transformants contained unique genomic DNA inserts
upstream of tnpR. The results of our screening of the H. pylori
transformants suggested that 70% of them contained unique in-
serts and that the inserts were smaller (0.65 kb) than those found
for the same library in E. coli. Although we are not certain, we
speculate that the average insert size in the H. pylori RIVET
library was smaller than the average insert size in pcat-T-lib-tnpR
either because the larger inserts had more potential sites for H.
pylori’s restriction systems or because larger inserts recombined
less efficiently. Our H. pylori RIVET library contained 3,340 in-
TABLE 2. Oligonucleotides used in this study
Oligonucleotide Sequence Reference
catseqst GAAGTATTATGAGGAGGGCG 19
catF2 CAACCGTGATATAGATTGAAAAGTGGAT This study
catF GATATAGATTGAAAAGTGGAT This study
catR2 CGCGCCCGGGATCCTCCTTG This study
tnpRbk75 TCAGTAAAGATGCGATTTGC 19
rrnB1 CCCTCGAGAATAAAACGAAAGGCTCAGTCG 19
G27_633_D1 GCCCTTAGTTCAGGTGTGGCAGTTTAAGG This study
G27_633_D2 CAAGGAGGATCCCGGCCGCGGCTACCTTCTCATTTCCTAGATAGTAGCC This study
G27_633_D3 ATCCACTTTTCAATCTATATCACGGTTGCCGGGAATGTGGGCATGCGAGTGGCG This study
G27_633_D4 GTTTTAGCGTCAATGTTGGGGTTGATTCTAATGG This study
G27_630_D1 GAGCTATGGGAAAGATAGAGGAAGCAATATCGC This study
G27_630_D2 CAAGGAGGATCCCGGCCGCGCCCTCTCCTTAATTTCATACTC This study
G27_630_D3 ATCCACTTTTCAATCTATATCACGGTTGGAACATTCTCATTTGTATGATTTGTTGAACGGG This study
G27_630_D4 GGGCTTGAATGTCAGTGATCCTGTC This study
G27_176_D1 GAGCGTGGATGGCAGGATCAGCGTTAAAG This study
G27_176_D2 CAAGGAGGATCCCGGCCGCGCTCATGCATGCTTAAACCCCACATCAAGGACG This study
G27_176_D3 ATCCACTTTTCAATCTATATCACGGTTGCGGGAGCAATCATGTTATCTTCTAATG This study
G27_176_D4 GAATCCACGCTATAGCCTTCTTGATAC This study
MobA_D1 CGCAATCAATCATGATAACCCTATTATATC This study
MobA_D2 CAAGGAGGATCCCGGGCGCGCCAACATACTTGGATCTTATTTGTTC This study
MobA_D3 ATCCACTTTTCAATCTATATCACGGTTGGAGAAGTTATAGTCGTTGGTATGGGCGGTAAG This study
MobA_D4 CTGGTTTACTTGACATTAGATCGATAAACAGGTG This study
HP0294end CTTGTCCTGTGGGCGATTTGC This study
HP0295end GACCGGCCGGATATGGCAG This study
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dependent clones that were pooled in groups of 10 and stored in
H. pylori freezing media at 80°C. These transformants covered
84% of the H. pylori genome (see Materials and Methods).
Identifying H. pylori host-induced promoters. To identify
putative host-induced promoters, we used the H. pylori RIVET
library strains to infect FVB/N mice (Fig. 2D). We screened 50
H. pylori RIVET library strains in parallel by infecting mice
with a mixture of 50 RIVET library strains. Baldwin and co-
workers showed that this pool size allows each strain to inde-
pendently establish an infection in the mouse gastric mucosa
(6). The infections were allowed to persist for 2 weeks, and
then we sacrificed the animals and harvested their stomachs.
The stomachs were homogenized, diluted, and plated on Cm-
containing media. After 4 days, each plate was replica plated
on both Cm-containing media and Km-containing media (Fig.
2D). RIVET strains that induced tnpR expression at any time
during the infection converted to Kms. The Kms strains were
rescued from the corresponding Cm-containing plates and
saved as frozen stocks for additional analysis. We screened
2,960 clones of our 3,340-clone H. pylori RIVET library and
thus approximately 74% of the H. pylori genome. Our screen-
ing analysis resulted in identification of 113 Kms H. pylori
RIVET strains. By using PCR amplification and sequencing of
the region cloned upstream of tnpR in these strains, we deter-
mined that the 113 Kms strains represented 13 unique clones
(see Table S1 in the supplemental material). We designated
these unique clones Pivi clones and the strains containing them
ivi strains; to identify a specific clone or strain, the number
corresponding to the order of ivi strain isolation was added to
its designation (Table 1).
Verifying that the Pivi clones were induced in the host. We
retested the Pivi clones identified as described above to ensure
that their expression in mice was greater than their expression
in vitro. The ivi strains, which were isolated from mouse stom-
achs as Kms strains, induced tnpR expression in vivo and thus
removed the res1-Km-res1 cassette from the H. pylori chromo-
some. Therefore, we reintroduced res1-Km-res1 into these
strains by transforming them to Kmr with the construct used to
create the original strain (pAW2rkr2) (see Materials and
Methods). Strains containing 1 of the 13 Pivi clones fused
upstream of tnpR and the res1-Km-res1 cassette (reconstructed
ivi strains) were designated by adding R to the end of the ivi
designation and were analyzed further to examine promoter-
directed expression of tnpR based on their conversion from
Kmr to Kms (Table 1).
To determine Pivi-directed expression of tnpR in the host,
we infected mice with each reconstructed ivi strain as a single
infecting strain. Each infection was allowed to persist for 2
weeks, and then we sacrificed the animals, harvested their
stomachs, and plated the stomachs to obtain single colonies on
Cm-containing media as described above. Plates containing the
colonies isolated from stomachs were then replica plated on
Cm-containing media and Km-containing media. The level of
promoter induction in vivo (expressed as a percentage) was
determined by dividing the number of Kms colonies by the
total number of colonies analyzed and multiplying the result by
100. To determine the in vitro expression conferred by each
Pivi clone, each reconstructed ivi strain was passaged on Cm-
containing media in the lab for 2 weeks (four or five passages)
and then plated on Cm-containing media to obtain single col-
onies. The resulting plates were replica plated on both Cm-
containing media and Km-containing media to determine the
level of promoter induction in vitro.
We found that 4 of the 13 Pivi clones originally isolated from
mice as Kms ivi strains conferred in vivo expression of tnpR
that was significantly higher than the in vitro expression when
the strains were tested as single infecting strains (as deter-
mined by two-tailed Student’s t test) (Fig. 3). These Pivi clones
were Pivi51 (P 	 0.001), Pivi66 (P 	 0.001), Pivi70 (P 	 0.05),
and Pivi77 (P 	 0.05). The values for two additional Pivi
clones, Pivi10 and Pivi67, were very close to our cutoff for
statistical significance, with P values of 	0.1. We included
these six Pivi clones in our subsequent analyses. The remaining
seven Pivi clones identified in our screen as Kms ivi strains did
not show in vivo induction of tnpR when they were retested as
single infecting strains (Fig. 3). It is possible that the Pivi clones
either were simply not induced in mice and were isolated as
background clones inherent in this screen or were induced only
when the strains were used in coinfections with additional
FIG. 3. Six RIVET-identified promoters were induced in the host.
The relative level of promoter induction of each of the 13 recon-
structed RIVET strains isolated from mice as Kms strains was analyzed
both in mice and in the lab. Promoter induction in the host was
analyzed using each reconstructed RIVET strain to independently
infect a group of mice for 2 weeks. Promoter induction in the lab was
analyzed after 2 weeks of in vitro growth on CHBA. For both in vivo
and in vitro experiments, the level of promoter induction was calcu-
lated by dividing the number of Kms CFU isolated by the total number
of CFU and multiplying the result by 100. All promoters indicated by
an asterisk were induced to a greater extent in vivo than in vitro. A
two-tailed Student t test was used to determine the following P values
for the promoters when in vitro induction and in vivo induction were
compared: for Pivi10, 	0.1; for Pivi51, 	0.001; for Pivi66, 	0.001; for
Pivi67, 	0.1; for Pivi70, 	0.05; and for Pivi77, 	0.05. The other pro-
moters did not differ appreciably under in vivo and in vitro conditions.
The error bars indicate standard deviations. For the RIVET strains,
the in vitro experiment was replicated two to six times and the in vivo
analysis was carried out using zero to nine mice, as follows: for Pivi2,
two in vitro replicates and five mice; for Pivi7, three in vitro replicates
and five mice; for Pivi10, three in vitro replicates and four mice; for
Pivi11, two in vitro replicates and one mouse; for Pivi23, three in vitro
replicates and nine mice; for Pivi39, six in vitro replicates and no mice;
for Pivi50, one in vitro replicate and two mice; for Pivi51, four in vitro
replicates and nine mice; for Pivi63, two in vitro replicates and two
mice; for Pivi66, six in vitro replicates and three mice; for Pivi67, two
in vitro replicates and three mice; for Pivi70, two in vitro replicates and
four mice; and for Pivi77, four in vitro replicates and three mice.
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strains, as was done in the screening of our H. pylori RIVET
library. Alternatively, retesting of only one Kms colony for each
unique Pivi clone could have contributed to a high false-neg-
ative rate. We did not perform additional studies to distinguish
between these possibilities.
Genomic location of in vivo-induced promoters. We modi-
fied the RIVET system for use with H. pylori so that it identi-
fied in vivo-induced promoters instead of specific in vivo-in-
duced genes. Thus, we were interested in determining the
genes regulated by our in vivo-induced promoters. To identify
these genes, we mapped the genomic locations of the six Pivi
clones on the H. pylori genome by comparing their sequences
to the sequence of the H. pylori strain G27 genome (Fig. 4 and
unpublished data). The locations of the Pivi clones in the G27
genome were the same as those in the previously described H.
pylori genomes with the exception of the location of Pivi10,
which is located on an endogenous plasmid (1, 61, 85). There-
fore, we used H. pylori strain 26695 annotation for all Pivi
clones except Pivi10 (85). The gene(s) regulated by each Pivi
clone is discussed below.
Pivi clones regulating H. pylori genes involved in interac-
tions with other cells. Three of the Pivi clones were located in
DNA regions upstream of a gene or set of genes potentially
used by H. pylori to interact with other bacterial cells or with
host cells. Pivi10 was located in the putative mobC gene up-
stream of the putative mobA, mobB, and mobD genes on an
endogenous H. pylori strain G27 plasmid (Fig. 4). About 50%
of H. pylori strains harbor endogenous plasmids (69), and plas-
mid DNA would have been isolated by our genomic DNA
preparation procedure and thus included in our pcat-T-lib-
tnpR and H. pylori RIVET libraries. mob genes encode relaxo-
some components required for plasmid nicking and mobiliza-
tion during horizontal gene transfer (32). Pivi66 mapped to the
CAG pathogenicity island in the cagY gene upstream of a
predicted operon containing cagZ, virB11, and virD4. The
CAG pathogenicity island is a 40-kb region containing 30
genes, and its presence is associated with H. pylori infections
that have more severe disease outcomes (21). Some of the gene
products encoded by the CAG pathogenicity island form a type
IV secretion apparatus known to inject at least two effectors,
CagA and peptidoglycan, into host cells (5, 88). While VirD4
and VirB11 are homologues of an adapter protein likely in-
volved in substrate export (2, 85) and an ATPase that gener-
ates energy for apparatus assembly and substrate export (77,
85), respectively, the function of CagZ is not known yet. Fi-
nally, Pivi77 overlapped the intergenic region upstream of one
of the uncharacterized vacA paralogues, HP0289 (85). vacA
encodes a well-characterized cytotoxic vacuolating protein be-
longing to the autotransporter family and is required by H.
pylori for full virulence (72, 90). The similarity of the HP0289
protein to VacA is concentrated mostly in the carboxy-terminal
autotransporter domain rather than in the cytotoxic vacuolat-
ing amino-terminal domain (55), and it is therefore not clear
what role the HP0289 protein may play in H. pylori virulence.
Pivi51 regulates the putative mesJ lysidine synthetase. Pivi51
overlaps mesJ and the upstream intergenic region and there-
fore likely regulates mesJ. mesJ, also called tilS in E. coli, is a
member of the PP-loop ATPase superfamily. Members of this
superfamily of proteins have distinct enzymatic functions but
share an ATP pyrophosphatase domain that targets the alpha-
beta bond of ATP (13). Recently, tilS was found to govern both
the codon and amino acid specificities of the isoleucine tRNA
(81). TilS is a lysidine synthetase that generates the lysidine
modification at the wobble position of the tRNAIle anticodon.
This changes the codon specificity from AUG to AUA and the
amino acid specificity from methionine to isoleucine (81).
Pivi70 regulates a putative metalloprotease. Another of the
in vivo-induced promoters, Pivi70, was located in open reading
frame HP0285, upstream of the H. pylori ftsH gene and two
hypothetical open reading frames, HP0287 and HP0288. ftsH
(HP0286) encodes a putative ATP-dependent metalloprotease
(33) and is essential for growth in E. coli. In E. coli this integral
inner membrane metalloprotease degrades both cytosolic pro-
teins, including sigma 32 and lambda CII (36, 37), and trans-
membrane proteins, including SecY and YccA (43, 44). FtsH
likely plays a role in cell division as an E. coli strain with a
temperature-sensitive ftsH allele exhibits filamentous growth at
restrictive temperatures (74). Two ftsH homologues, HP0286
and HP1069, are present in H. pylori; Ge and Taylor (33)
showed that HP1069 is essential. There have been no studies to
date of HP0286-encoded FstH, and H. pylori FtsH targets have
not been identified yet. The products of HP0287 and HP0288,
FIG. 4. Locations of in vivo-induced promoters on the H. pylori
chromosome or an endogenous plasmid. Each in vivo-induced pro-
moter is represented by an open box, and the arrow below the box
indicates the direction in which the promoter was cloned. The open
reading frames overlapped by and in the genomic region of the in
vivo-induced promoters are indicated by thick arrows. (A) Pivi10 is 153
bp long and overlaps the mobC gene in the H. pylori strain mG27
endogenous plasmid. It likely regulates mobA, mobB, and mobD.
(B) Pivi51 is 95 bp long and overlaps mesJ and the intergenic region
upstream of mesJ and thus likely regulates mesJ. (C) Pivi66 is 166 bp
long and is located within cagY, upstream of a putative operon con-
taining cagZ, virB11, and virD4. (D) Pivi67 is 133 bp long and overlaps
HP1359, ubiA, and the intergenic region between them. There are six
genes that are potentially regulated by Pivi67, including three unchar-
acterized open reading frames (HP1359, HP1358, and HP1354) psd,
nadA, and nadC. (E) Pivi70 is 119 bp long and is located within
HP0286. Pivi70 potentially regulates the metalloprotease gene ftsH
and uncharacterized open reading frames HP0287 and HP0288.
(F) Pivi77 is 1,679 bp long and overlaps HP0288, HP0289, and the
intergenic region between them. Pivi77 likely regulates the vacA para-
logue encoded by HP0289.
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which are two hypothetical open reading frames located down-
stream of fstH, show no homology to previously identified
proteins (85).
Pivi67 regulates previously uncharacterized proteins. Pivi67,
the last of the in vivo-induced promoters identified in our
analysis, was located upstream of six open reading frames
predicted to be in the same operon. These open reading frames
included two hypothetical open reading frames, HP1359 and
HP1358, followed by psd (encoding a phosphatidyl serine de-
carboxylase), nadA (encoding a quinolinate synthetase A),
nadC (encoding a nicotinate dinucleotide pyrophosphorylase),
and an open reading frame encoding a putative adenine-spe-
cific methyltransferase.
Genes regulated by Pivi clones play a role in H. pylori colo-
nization of the host. To address our goal of identifying H. pylori
genes required for host colonization and/or disease develop-
ment, we created deletion mutants with mutations in genes
potentially regulated by our Pivi clones and analyzed these
mutants to determine mouse colonization phenotypes. When
there was more than one gene potentially regulated by our Pivi
clones, we attempted to construct a mutant with a deletion of
the gene immediately downstream of the promoter. Thus, we
created mutants with deletions of the mobA and cagZ genes,
which were immediately downstream of Pivi10 and Pivi66, re-
spectively. However, since the mobB and mobD open reading
frames are located in the mobA open reading frame, we actu-
ally created a mobABD triple-deletion strain. Several unsuc-
cessful attempts were made to delete HP1359, the hypothetical
open reading frame downstream of Pivi67, and ftsH, the metal-
loprotease gene downstream of Pivi70. Our inability to delete
these genes is consistent with the hypothesis that they are
essential for viability, as proposed by other workers (73). Fi-
nally, we did not analyze HP0289 and mesJ, the open reading
frames downstream of Pivi77 and Pivi51, respectively.
H. pylori nonpolar deletion mutants were constructed by
replacing the open reading frame of interest with the cat gene,
which conferred Cmr (see Materials and Methods). Deletion
and insertion cassettes were generated using a sewing PCR
strategy described by Chalker et al. (22) that allows efficient
gene deletion and replacement with a cat gene. The cagZ gene
was deleted in the H. pylori SS1 strain commonly used for
analyzing H. pylori phenotypes in mice because this strain re-
producibly infects mice. To address the possibility that cagZ is
differently regulated in the SS1 strain, we verified that the
promoter regulating cagZ was similarly induced in the mG27
and SS1 strains, i.e., 77.3 and 76%, respectively (Fig. 3). The
mobABD genes were deleted in mG27 since we knew that this
strain contains the endogenous plasmid from which Pivi10 was
isolated. mG27 infects mice at levels that are approximately
10-fold less than the H. pylori SS1 strain levels. In each case,
Cmr transformants were selected and analyzed by PCR to
verify deletion of the cagZ and mobABD loci. Deletion of cagZ
and mobABD were unlikely to have polar effects on down-
stream genes, as we verified expression of the gene down-
stream of cagZ in the cagZ strain by reverse transcription-
PCR (data not shown) and there is a putative transcriptional
terminator downstream of mobABD (38). Finally, deletion of
mobABD and deletion of cagZ did not confer in vitro growth
defects when we used the mutant strains in in vitro competition
assays with the wild-type mG27 and SS1 strains, respectively
(Table 3).
To assess the contribution of cagZ and mobABD to H. pylori
colonization of mice, we carried out both single-strain infection
studies and coinfection studies. For single-strain infection
studies we infected groups of five mice with each mutant strain
(cagZ or mobABD) and each wild-type strain (SS1 or
mG27). For the coinfection studies a mutant strain (cagZ or
mobABD) was used to infect a group of five mice along with
the wild-type passage control strain (SS1 and mG27, respec-
tively). Single-strain studies and coinfection studies for each
mutant–wild-type strain pair were carried out simultaneously
using the same mutant strain and wild-type strain inocula so we
could be confident of the mutant strain behavior in the coin-
fection study.
When it was used as the only infecting strain, the cagZ
strain had a colonization fitness similar to that of the wild-type
strain (Fig. 5). Interestingly, however, when mice were infected
with the cagZ strain along with the wild-type strain, the
FIG. 5. The cagZ H. pylori mutant outcompetes the wild-type
strain in a coinfection colonization assay. Single-strain infection and
coinfection studies with H. pylori cagZ and wild-type strains were
carried out using FVB/N mice for 2 weeks as described in Materials
and Methods. The results of one representative set of experiments are
shown. Each point represents one mouse stomach, and the solid lines
indicate the averages. When the cagZ mutant strain was coinfected
with the wild-type strain, we were unable to detect any wild-type strain
and thus placed its concentration at the limit of detection (200 CFU/g).
This suggests that the cagZ mutant strain outcompeted the wild-type
strain for colonization (competitive index, 5,713).
TABLE 3. In vitro growth competition between the mobABD and
cagZ mutants and the correspoding isogenic wild-type strains
Strains
Ratio of mutant to wild type ata:
Zero
time 3 h 6 h 12 h 18 h 24 h 30 h
SS1 cagZ  wild type 0.7 0.7 1.4 0.4 0.5 0.2
mG27 mobABD  wild type 0.1 1.2 0.5 0.7 0.9 0.9
a Ratios of the mutant to the wild type in an in vitro growth competition
experiment at different times. Strains were grown BB10 with shaking under
microaerobic conditions. The wild-type strains are isogenic with the correspond-
ing mutants. Each competition assay was repeated two times, and similar results
were obtained. The results for one replicate for each mutant are shown.
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cagZ strain outcompeted the wild-type strain; no wild-type
cells or a reduced number of wild-type cells were isolated from
the stomachs of mice coinfected with the wild-type and cagZ
strains (Fig. 5 and data not shown). We calculated that the
competitive indices were 5,713 for one coinfection experiment
(Fig. 5) and 20 for a second coinfection experiment. These
competitive indices suggest that the cagZ strain outcompetes
the wild-type strain in mice by approximately 1 to 3 orders of
magnitude. These results intriguingly suggest that elevated
transcription of cagZ in mice actually decreases the bacteri-
um’s colonization ability, and they are consistent with the no-
tion that genes identified by our RIVET analysis play roles in
host colonization.
When the mobABD strain was used as the only infecting
strain in mice, overall it infected the animals less well than the
wild-type strain (Fig. 6). Only three of the five mice treated
with the mobABD strain became infected, and the mice that
were infected had a bacterial stomach load (CFU/g) that was
about 0.5 log lower than that of mice infected with the wild-
type strain. Consistent with this defect, the mobABD mutant
strain was not detected in plates containing stomachs of mice
coinfected with the mobABD mutant and wild-type H. pylori
strains (competitive index, 0.007). Since the mobABD strain
performed like the wild-type strain in in vitro growth and
competition studies (Table 3), these results suggest that the
MobABD proteins are important for promoting stomach col-
onization. However, complementation studies in which we re-
introduced the mobABD and cagZ genes into our mobABD
and cagZ mutant strains, respectively, are required to be
certain that these genes are responsible for the stomach colo-
nization phenotypes, although these mutant strains had no
other detectable defects (see Materials and Methods).
DISCUSSION
In this study, we used RIVET with H. pylori and identified six
promoters that are induced in response to murine host stom-
achs. We created deletions in two of the genes putatively reg-
ulated by these in vivo-induced promoters and found that they
are important for host colonization. The mobABD mutant
strain was defective for host colonization in both single-infec-
tion and coinfection studies, and interestingly, the cagZ mu-
tant strain outcompeted the wild-type control strain in coin-
fection studies. Our findings support the hypothesis that H.
pylori factors important for colonization can be successfully
identified as in vivo-induced genes using the RIVET system.
RIVET analysis of H. pylori. RIVET has proven to be a
valuable tool for identifying bacterial genes important for
growth in specific niches, such as inside a host (14, 18, 51, 76,
87). The use of RIVET in this study was the first time that a
screen of this kind has been done with H. pylori. The advantage
of RIVET over other in vivo expression technology systems is
that it detects transient gene induction in a small number of
cells. RIVET also allows identification of niche-regulated
genes expressed at different levels (18, 63). In our RIVET
analysis, we combined the tnpR allele with a wild-type ribosome-
binding site and the res1 allele, which was recombined with 10-
fold-reduced efficiency compared to the wild-type res allele (48,
59). This combination was used to identify H. pylori genes that
were expressed in the lab, induced in the mouse stomach envi-
ronment, and are important for mouse colonization.
RIVET identifies novel and previously identified host-in-
duced genes. Several previous studies identified H. pylori host-
induced genes with the goal of finding candidate colonization
and disease-promoting factors (11, 12, 34, 45, 78). These stud-
ies were carried out both in vivo using humans, Rhesus ma-
caques, and Mongolian gerbils and in vitro using a gastric
epithelial cell line (11, 12, 34, 45, 78). Only our Pivi66 promoter
was also identified by these studies. Pivi66 maps to the CAG
pathogenicity island and regulates a predicted operon includ-
ing HP0524 (virD4), HP0525 (virB11), and HP0526 (cagZ).
HP0524 is induced in the Rhesus macaque infection model,
and HP0525 is induced in both the Rhesus macaque and Mon-
golian gerbil infection models (11, 78). This small overlap in
the identification of host-induced genes between RIVET and
previous studies both validates the RIVET method and high-
lights the conclusion that RIVET identified a set of unique
host-induced genes.
Pivi66 regulates CAG pathogenicity island genes. Pivi66 pu-
tatively regulates a set of three genes, HP0524 (virD4), HP0525
(virB11), and HP0526 (cagZ), that are located in the H. pylori
CAG pathogenicity island. Most of the genes in the CAG
pathogenicity island, including virD4, virB11, and cagZ, have
been analyzed to examine their roles in host colonization,
interleukin-8 (IL-8) induction, and CagA transport (30). Inter-
estingly, although virD4, virB11, and cagZ are predicted to be
in an operon, their contribution to cag pilus function and
mouse colonization appears to be distinct. VirD4 is not re-
quired for IL-8 induction, but it is important for CagA trans-
port into gastric epithelial cells (30). VirB11 is important for
both IL-8 induction and CagA transport into gastric epithelial
cells. CagZ contributes to both cag functions as the cagZ
strain induces IL-8 and transports CagA at reduced levels
FIG. 6. The mobABD H. pylori mutant is defective for host
colonization. Single-strain infection and coinfection studies with H.
pylori mobABD and wild-type strains were carried out using
FVB/N mice for 2 weeks. Each point represents one mouse stom-
ach, and the solid lines indicate the averages. The mobABD mu-
tant was not recovered from stomach plates prepared for mice
coinfected with both the mobABD mutant and wild-type strain,
indicating that it was outcompeted by the wild-type strain (compet-
itive index, 0.007).
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compared to wild-type H. pylori strains (30). Both the virD4
and virB11 mutant H. pylori strains were attenuated for
mouse colonization in single-infection studies, while the cagZ
strain infected mice at levels similar to the levels of infection of
the wild-type strain in single-strain infection studies (56; this
study). We observed, however, that the cagZ strain had a
colonization advantage during coinfection. It is not clear that
the reduced cag function of the cagZ mutant is responsible
for the enhanced colonization phenotype that we observed.
The crystal structure and protein interaction profile of CagZ
are consistent with a chaperonelike function for CagZ (20),
because of the presence of a disordered carboxy-terminal tail
and a highly negatively charged surface. Members of a class of
chaperones important for delivery of type III effectors, includ-
ing CesT from enterohemorrhagic E. coli and SigE from Sal-
monella spp., have a unique structure, but they also have neg-
atively charged surfaces (52). It is possible that CagZ
contributes directly to the transport of the CagA effector; how-
ever, since CagZ is not absolutely required for CagA transport,
this seems unlikely. Another possibility is that CagZ has a
chaperonelike function for assembly of the cag secretion pilus.
In fact, CagZ was found to interact with 10 Cag proteins
(CagY, CagX, CagV, CagT, CagS, CagM, CagI, CagG, CagF,
and CagE) in yeast two-hybrid and coimmunoprecipitation
studies (16). Many of these proteins form the channel or core
of the cag pilus structure (4). We hypothesize that CagZ may
in fact provide chaperone activity and help assemble antigens,
similar to the role proposed for CagY (70). If this prediction is
correct, cagZ mutants would have less CAG pilus antigenicity
and might have been able to avoid an anti-CAG immune re-
sponse that would have targeted the wild-type strain. Such
immune avoidance could have conferred the enhanced coloni-
zation phenotype. Future Cag protein assembly experiments
with a cagZ strain will address this hypothesis.
In vivo-induced promoter regulates genes with putative
roles in horizontal gene transfer. DNA transfer via conjuga-
tion is a common mechanism for sharing genetic material that
can contribute to the success of pathogenic bacteria (26). Con-
jugation is the transfer of DNA from a bacterial donor to a
recipient cell by direct cell-to-cell contact. We identified a
group of H. pylori endogenous plasmid-borne genes, mobA,
mobB, and mobD, as genes that are induced during mouse
infection and are important for mouse colonization. The mob
genes have been shown to be important for DNA transfer via
conjugation in other microbes. The mob genes encode a relax-
ase (mobA) and accessory proteins (mob and mobD) that make
up a complex called the relaxosome. The relaxosome functions
by (i) nicking the DNA molecule to be transferred at the origin
of transfer, (ii) becoming covalently associated with the 5
 end
of the single-stranded DNA, (iii) transporting the DNA mol-
ecule to the conjugation machinery at the inner cell membrane
via a coupling protein, and (iv) transporting the DNA molecule
across the bacterial membranes through the conjugation ma-
chinery into the recipient cell (49). The other components
important for DNA transfer via conjugation include the cou-
pling protein mentioned above, the transmembrane protein
complex, and the conjugation pilus (7, 50). DNA transfer via
conjugation is a widespread method of horizontal gene transfer
in the prokaryotic world and has been documented to occur
between prokaryotes and eukaryotes as well, including yeast,
plant, and mammalian cells (15, 46, 89, 92).
DNA transfer via conjugation has been shown to occur be-
tween H. pylori clinical isolates and between H. pylori and
Campylobacter jejuni (3, 65). Specific conjugation component
homologues have been identified in H. pylori, including two
chromosomally encoded relaxase proteins, Rlx1 and Rlx2, and
two chromosomally encoded coupling proteins, TraG and
VirD4 (3). Only Rlx1 and TraG, however, are important for
DNA transfer via conjugation (3). Also present in H. pylori are
three systems ancestrally related to conjugation machinery,
including the cag, comB, and tfs3 type IV secretions systems
(24, 39, 42). Interestingly, none of these three systems appears
to be important for conjugation (3). The role of conjugation in
H. pylori infection biology is not clear yet, however. About 30%
of the H. pylori clinical isolates characterized contain the mob
region (38), and it is possible that the mobA-encoded relaxase
is important for initiating plasmid transfer in some H. pylori
strains.
In vivo-induced promoter regulates a vacA paralogue. Three
vacA paralogues are present in each of the three published H.
pylori genomes (the H. pylori 26695, J99, and HPAG1 ge-
nomes) and in our unpublished genome for the G27 strain (1,
61, 85). The amino termini of the proteins encoded by the vacA
paralogues (the HP0289, HP0610, and HP0922 proteins) are
not well conserved among the paralogues, and each paralogue
is not well conserved among the sequenced H. pylori strains (1,
61, 85). Like VacA, these proteins belong to the autotrans-
porter protein family based on primary sequence homology.
Autotransporters are characterized by three domains, (i) a sec
signal peptide for transport across the cytoplasmic membrane,
(ii) an amino terminus that confers a unique catalytic function,
and (iii) a  domain that forms a porelike structure in the outer
membrane and transports the amino terminus across the outer
membrane. The amino-terminal domain then either remains
associated with the outer membrane or is cleaved and secreted,
as observed for VacA (29). Most of the homology between the
vacA paralogues and vacA is in the sequences encoding the
carboxy-terminal  domains. The HP0289, HP0610, and
HP0922 proteins are therefore unlikely to have the same cy-
totoxic activity as VacA. Based on their primary sequences,
these proteins also lack the cleavage site that would suggest
that they are secreted into the extracellular milieu (85).
Although the function of the vacA paralogues in H. pylori
virulence is not evident from their primary sequences, recent
studies have suggested that they are important for coloniza-
tion. The identification of HP0289 in a signature-tagged mu-
tagenesis screen for gerbil colonization mutants suggests that
HP0289 has a role in colonization (41). Another of the vacA
paralogues, HP0610, was also found to be important for colo-
nization in a murine model (6). The fact that the third vacA
paralogue, HP0922, was not identified by either of these
screens may indicate that it is not important for animal colo-
nization, but it more likely reflects the difficulty of generating
completely saturating screens for H. pylori. Additionally, future
analyses of the sequences encoding amino-terminal passenger
domains of the vacA paralogues may reveal their contributions
to host colonization.
In vivo-induced promoters regulate essential genes. Three
of the in vivo-induced promoters identified in this analysis
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regulate H. pylori genes that are likely essential for in vitro
growth. Our unsuccessful attempts to create deletions in
HP1359 and ftsH found downstream of Pivi67 and Pivi70, re-
spectively, suggest that these genes are essential, as proposed
by other workers (73). Although analysis of essential genes to
determine their contributions to H. pylori colonization and
virulence poses a unique set of challenges, these genes may
produce a novel set of H. pylori virulence factors. The recent
development of an inducible gene expression system for H.
pylori should expedite the study of these essential genes (10).
In summary, development and use of RIVET for H. pylori
identified six sets of genes, two of which are important in
animal colonization, as shown here. Further, the development
of RIVET for H. pylori should provide powerful tools for
studying H. pylori gene expression and gene regulation in the
host environment.
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